SPDR S&P Biotech (XBI) 65.67 $XBI
Downtrend Call Working As SPDR S&P Biotech ETF Stock Falls 9.0% (XBI)
Comtex SmarTrend(R) - Thu Oct 22, 9:43AM CDT
SmarTrend identified a Downtrend for SPDR S&P Biotech ETF (AMEX:XBI) on September 25th, 2015 at $69.95. In approximately 4 weeks, SPDR S&P Biotech ETF has returned 9.01% as of today's recent price of $63.65.
XBI: 65.67 (+1.48)
Shareholder Alert: 4 Stocks Ready to Make a Move
ACCESSWIRE - Mon Oct 19, 11:17AM CDT
WINDSOR, ONTARIO / ACCESSWIRE / October 19, 2015 / The Wealthy Biotech Trader (or "WBT"
, an investment newsletter focused on showing everyday investors new opportunities in rapidly growing, little-known, biotech, pharma, medical device and general healthcare stocks making news and subsequent market moves, is alerting traders about several trade ideas within the very healthy medical device sector.
LOXO: 25.09 (+0.98), XBI: 65.67 (+1.48), FORD: 1.11 (-0.04)
Watch for SPDR S&P Biotech ETF to Potentially Rebound After Falling 4.41% Yesterday
Comtex SmarTrend(R) - Tue Oct 13, 4:00PM CDT
SPDR S&P Biotech ETF (AMEX:XBI) traded in a range yesterday that spanned from a low of $61.16 to a high of $65.20. Yesterday, the shares fell 4.4%, which took the trading range below the 3-day low of $61.38 on volume of 5.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
XBI: 65.67 (+1.48)
SPDR S&P Biotech ETF Down 7.4% Since SmarTrend Downtrend Call (XBI)
Comtex SmarTrend(R) - Tue Oct 13, 11:54AM CDT
SmarTrend identified a Downtrend for SPDR S&P Biotech ETF (AMEX:XBI) on September 25th, 2015 at $69.95. In approximately 3 weeks, SPDR S&P Biotech ETF has returned 7.38% as of today's recent price of $64.79.
XBI: 65.67 (+1.48)
Zacks Investment Ideas feature highlights: iShares Nasdaq Biotechnology, SPDR S&P Biotech ETF, ProShares Short S&P500, ProShares UltraShort S&P500 and ProShares UltraPro Short S&P500
Zacks Equity Research - Zacks Investment Research - Mon Oct 12, 8:30AM CDT
Zacks Investment Ideas feature highlights: iShares Nasdaq Biotechnology, SPDR S&P Biotech ETF, ProShares Short S&P500, ProShares UltraShort S&P500 and ProShares UltraPro Short S&P500
SPXU: 31.41 (-1.07), SH: 20.74 (-0.24), SDS: 19.74 (-0.46), XBI: 65.67 (+1.48), IBB: 316.28 (+10.17)
Protea: A High Quality Small-Cap to Ride Out Biotech's Drop
ACCESSWIRE - Mon Oct 12, 8:16AM CDT
REDONDO BEACH, CA / ACCESSWIRE / October 12, 2015 / The SPDR S&P Biotech ETF (ARCA: XBI) has fallen more than 20% over the past three months, which significantly outpaced the S&P 500's 4.7% fall over the same timeframe. With the House of Representatives subpoenaing Valeant Pharmaceuticals International Inc. (NYSE: VRX) for documents related to drug price increases, the market is concerned that the federal government may be stepping up its efforts to curb increases in drug prices.
VRX: 116.16 (+6.29), FMI: 22.42 (+0.66), XBI: 65.67 (+1.48), WAT: 124.27 (+1.09), VRX.TO: 152.69 (+8.64)
Juno Therapeutics (JUNO) Stock Could Lead the Way to a Biotech Bounce
at The Street - Fri Oct 09, 10:40AM CDT
We're watching the SPDR S&P Biotech ETF and its components for clues to a rally. Rejected lows in the charts have been encouraging.
XBI: 65.67 (+1.48), JUNO: 49.22 (+1.82)
Charting a Biotech Bounce
at The Street - Fri Oct 09, 10:10AM CDT
We're watching the SPDR S&P Biotech ETF for clues to a rally. Rejected lows in the charts have been encouraging.
XBI: 65.67 (+1.48), JUNO: 49.22 (+1.82)
7 Huge Mistakes Every ETF Investor Needs to Avoid
Eric Dutram - Zacks Investment Research - Fri Oct 09, 9:45AM CDT
These are some of the most common misconceptions about ETF investing, make sure you do not make the same mistakes!
SPY: 207.51 (+2.25), VXX: 18.63 (+0.19), GLD: 111.50 (-0.19), XBI: 65.67 (+1.48), IBB: 316.28 (+10.17), IAU: 11.25 (-0.02)
Correction in Health Care Stocks Remains in Full Force
at The Street - Thu Oct 08, 3:00PM CDT
Have we reached the point where something will be done about it?
CI: 132.54 (+3.05), ANTM: 140.95 (+1.54), HCA: 68.98 (+2.90), XBI: 65.67 (+1.48), UNH: 115.92 (+2.11), IBB: 316.28 (+10.17), XLV: 69.33 (+1.45)
3 Large-Cap Biotech Stocks Whose Valuations Should Make You Skeptical
Sean Williams, The Motley Fool - Motley Fool - Wed Oct 07, 7:03AM CDT
Source: Federal Reserve Bank of New York. With the exception of the last couple of weeks, the biotech sector has been a vast outperformer since the Great Recession. The broad-based S&P 500 has pretty much tripled since hitting its lows in...
BIIB: 276.99 (+0.16), VRTX: 114.37 (+4.88), XBI: 65.67 (+1.48), INCY: 110.02 (+1.00)
SPDR S&P Biotech ETF Rises 4.89% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Fri Oct 02, 4:07PM CDT
SPDR S&P Biotech ETF (AMEX:XBI) traded in a range yesterday that spanned from a low of $60.45 to a high of $65.75. Yesterday, the shares gained 4.9%, which took the trading range above the 3-day high of $64.56 on volume of 9.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
XBI: 65.67 (+1.48)
Biotech ETFs Looking Attractive After Sell-Off
Sweta Killa - Zacks Investment Research - Thu Oct 01, 7:55AM CDT
The current slide in biotech sector made the stocks valuation attractive at the current levels.
BBP: 29.34 (+0.55), SBIO: 28.96 (+1.28), XBI: 65.67 (+1.48), IBB: 316.28 (+10.17)
Top ETF Stories of September
Zacks Equity Research - Zacks Investment Research - Wed Sep 30, 12:34PM CDT
Inside the top financial stories of September and their impact on the world of ETFs.
73.08 (-1.41), KRE: 43.14 (+0.99), BBC: 27.06 (+0.75), SBIO: 28.96 (+1.28), VRX: 116.16 (+6.29), EWG: 27.20 (+0.45), IAI: 40.57 (+0.67), REM: 10.27 (-0.01), XBI: 65.67 (+1.48), EDV: 118.36 (-1.34), IBB: 316.28 (+10.17), GDX: 16.52 (+0.40)
Notable ETF Inflow Detected - XBI, ZIOP, ACHN, ZFGN
ETFChannel.com - Wed Sep 30, 9:52AM CDT
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF where we have detected an approximate $186.0 million dollar inflow -- that's a 10.1% increase...
XBI: 65.67 (+1.48)
Look for Shares of SPDR S&P Biotech ETF to Potentially Rebound after Yesterday's 7.19% Sell Off
Comtex SmarTrend(R) - Mon Sep 28, 4:09PM CDT
SPDR S&P Biotech ETF (AMEX:XBI) traded in a range yesterday that spanned from a low of $61.28 to a high of $67.06. Yesterday, the shares fell 7.2%, which took the trading range below the 3-day low of $65.98 on volume of 14.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
XBI: 65.67 (+1.48)
Drug Pricing Fears Erase Biotech Stock Gains for the Year
at The Street - Mon Sep 28, 12:33PM CDT
The bloodletting in biotech stocks continued Monday with aggressive selling erasing the year's gains in a key sector exchange-traded fund. Another closely-followed ETF is barely hanging on to its outperformance.
BIIB: 276.99 (+0.16), VRX: 116.16 (+6.29), XBI: 65.67 (+1.48), IBB: 316.28 (+10.17)
Downtrend Call Working As SPDR S&P Biotech ETF Stock Falls 9.0% (XBI)
Comtex SmarTrend(R) - Thu Oct 22, 9:43AM CDT
SmarTrend identified a Downtrend for SPDR S&P Biotech ETF (AMEX:XBI) on September 25th, 2015 at $69.95. In approximately 4 weeks, SPDR S&P Biotech ETF has returned 9.01% as of today's recent price of $63.65.
XBI: 65.67 (+1.48)
Shareholder Alert: 4 Stocks Ready to Make a Move
ACCESSWIRE - Mon Oct 19, 11:17AM CDT
WINDSOR, ONTARIO / ACCESSWIRE / October 19, 2015 / The Wealthy Biotech Trader (or "WBT"
, an investment newsletter focused on showing everyday investors new opportunities in rapidly growing, little-known, biotech, pharma, medical device and general healthcare stocks making news and subsequent market moves, is alerting traders about several trade ideas within the very healthy medical device sector. LOXO: 25.09 (+0.98), XBI: 65.67 (+1.48), FORD: 1.11 (-0.04)
Watch for SPDR S&P Biotech ETF to Potentially Rebound After Falling 4.41% Yesterday
Comtex SmarTrend(R) - Tue Oct 13, 4:00PM CDT
SPDR S&P Biotech ETF (AMEX:XBI) traded in a range yesterday that spanned from a low of $61.16 to a high of $65.20. Yesterday, the shares fell 4.4%, which took the trading range below the 3-day low of $61.38 on volume of 5.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
XBI: 65.67 (+1.48)
SPDR S&P Biotech ETF Down 7.4% Since SmarTrend Downtrend Call (XBI)
Comtex SmarTrend(R) - Tue Oct 13, 11:54AM CDT
SmarTrend identified a Downtrend for SPDR S&P Biotech ETF (AMEX:XBI) on September 25th, 2015 at $69.95. In approximately 3 weeks, SPDR S&P Biotech ETF has returned 7.38% as of today's recent price of $64.79.
XBI: 65.67 (+1.48)
Zacks Investment Ideas feature highlights: iShares Nasdaq Biotechnology, SPDR S&P Biotech ETF, ProShares Short S&P500, ProShares UltraShort S&P500 and ProShares UltraPro Short S&P500
Zacks Equity Research - Zacks Investment Research - Mon Oct 12, 8:30AM CDT
Zacks Investment Ideas feature highlights: iShares Nasdaq Biotechnology, SPDR S&P Biotech ETF, ProShares Short S&P500, ProShares UltraShort S&P500 and ProShares UltraPro Short S&P500
SPXU: 31.41 (-1.07), SH: 20.74 (-0.24), SDS: 19.74 (-0.46), XBI: 65.67 (+1.48), IBB: 316.28 (+10.17)
Protea: A High Quality Small-Cap to Ride Out Biotech's Drop
ACCESSWIRE - Mon Oct 12, 8:16AM CDT
REDONDO BEACH, CA / ACCESSWIRE / October 12, 2015 / The SPDR S&P Biotech ETF (ARCA: XBI) has fallen more than 20% over the past three months, which significantly outpaced the S&P 500's 4.7% fall over the same timeframe. With the House of Representatives subpoenaing Valeant Pharmaceuticals International Inc. (NYSE: VRX) for documents related to drug price increases, the market is concerned that the federal government may be stepping up its efforts to curb increases in drug prices.
VRX: 116.16 (+6.29), FMI: 22.42 (+0.66), XBI: 65.67 (+1.48), WAT: 124.27 (+1.09), VRX.TO: 152.69 (+8.64)
Juno Therapeutics (JUNO) Stock Could Lead the Way to a Biotech Bounce
at The Street - Fri Oct 09, 10:40AM CDT
We're watching the SPDR S&P Biotech ETF and its components for clues to a rally. Rejected lows in the charts have been encouraging.
XBI: 65.67 (+1.48), JUNO: 49.22 (+1.82)
Charting a Biotech Bounce
at The Street - Fri Oct 09, 10:10AM CDT
We're watching the SPDR S&P Biotech ETF for clues to a rally. Rejected lows in the charts have been encouraging.
XBI: 65.67 (+1.48), JUNO: 49.22 (+1.82)
7 Huge Mistakes Every ETF Investor Needs to Avoid
Eric Dutram - Zacks Investment Research - Fri Oct 09, 9:45AM CDT
These are some of the most common misconceptions about ETF investing, make sure you do not make the same mistakes!
SPY: 207.51 (+2.25), VXX: 18.63 (+0.19), GLD: 111.50 (-0.19), XBI: 65.67 (+1.48), IBB: 316.28 (+10.17), IAU: 11.25 (-0.02)
Correction in Health Care Stocks Remains in Full Force
at The Street - Thu Oct 08, 3:00PM CDT
Have we reached the point where something will be done about it?
CI: 132.54 (+3.05), ANTM: 140.95 (+1.54), HCA: 68.98 (+2.90), XBI: 65.67 (+1.48), UNH: 115.92 (+2.11), IBB: 316.28 (+10.17), XLV: 69.33 (+1.45)
3 Large-Cap Biotech Stocks Whose Valuations Should Make You Skeptical
Sean Williams, The Motley Fool - Motley Fool - Wed Oct 07, 7:03AM CDT
Source: Federal Reserve Bank of New York. With the exception of the last couple of weeks, the biotech sector has been a vast outperformer since the Great Recession. The broad-based S&P 500 has pretty much tripled since hitting its lows in...
BIIB: 276.99 (+0.16), VRTX: 114.37 (+4.88), XBI: 65.67 (+1.48), INCY: 110.02 (+1.00)
SPDR S&P Biotech ETF Rises 4.89% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Fri Oct 02, 4:07PM CDT
SPDR S&P Biotech ETF (AMEX:XBI) traded in a range yesterday that spanned from a low of $60.45 to a high of $65.75. Yesterday, the shares gained 4.9%, which took the trading range above the 3-day high of $64.56 on volume of 9.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
XBI: 65.67 (+1.48)
Biotech ETFs Looking Attractive After Sell-Off
Sweta Killa - Zacks Investment Research - Thu Oct 01, 7:55AM CDT
The current slide in biotech sector made the stocks valuation attractive at the current levels.
BBP: 29.34 (+0.55), SBIO: 28.96 (+1.28), XBI: 65.67 (+1.48), IBB: 316.28 (+10.17)
Top ETF Stories of September
Zacks Equity Research - Zacks Investment Research - Wed Sep 30, 12:34PM CDT
Inside the top financial stories of September and their impact on the world of ETFs.
73.08 (-1.41), KRE: 43.14 (+0.99), BBC: 27.06 (+0.75), SBIO: 28.96 (+1.28), VRX: 116.16 (+6.29), EWG: 27.20 (+0.45), IAI: 40.57 (+0.67), REM: 10.27 (-0.01), XBI: 65.67 (+1.48), EDV: 118.36 (-1.34), IBB: 316.28 (+10.17), GDX: 16.52 (+0.40) Notable ETF Inflow Detected - XBI, ZIOP, ACHN, ZFGN
ETFChannel.com - Wed Sep 30, 9:52AM CDT
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF where we have detected an approximate $186.0 million dollar inflow -- that's a 10.1% increase...
XBI: 65.67 (+1.48)
Look for Shares of SPDR S&P Biotech ETF to Potentially Rebound after Yesterday's 7.19% Sell Off
Comtex SmarTrend(R) - Mon Sep 28, 4:09PM CDT
SPDR S&P Biotech ETF (AMEX:XBI) traded in a range yesterday that spanned from a low of $61.28 to a high of $67.06. Yesterday, the shares fell 7.2%, which took the trading range below the 3-day low of $65.98 on volume of 14.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
XBI: 65.67 (+1.48)
Drug Pricing Fears Erase Biotech Stock Gains for the Year
at The Street - Mon Sep 28, 12:33PM CDT
The bloodletting in biotech stocks continued Monday with aggressive selling erasing the year's gains in a key sector exchange-traded fund. Another closely-followed ETF is barely hanging on to its outperformance.
BIIB: 276.99 (+0.16), VRX: 116.16 (+6.29), XBI: 65.67 (+1.48), IBB: 316.28 (+10.17)
